Evaluating Paternal Antigen Exposure

Overview

About this study

The purpose of this study is to determine the characteristics of immune tolerance phenotypes in primiparous and multiparous pregnancies of same versus differing paternity.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Pregnant patients seen for prenatal care in Rochester and deliver within the Mayo Clinic Health Systems
Ability to provide informed written consent
Known paternity for pregnancy
Singleton pregnancies

Exclusion Criteria:

Mothers < 18 years of age
Multiple fetuses

Eligibility last updated 9/8/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Elizabeth Ann Enninga, Ph.D.	Open for enrollment	Contact information: Maureen Lemens C.C.R.C. (507) 293-1487 Lemens.Maureen@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elizabeth Ann Enninga, Ph.D.

Open for enrollment

Contact information:

Maureen Lemens C.C.R.C.

(507) 293-1487

Lemens.Maureen@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials